This is where the posters I presented this year at #AACR23 and #ASCO23 have ended up for now @BrownUCancer @BrownMedicine @BrownUniversity @BrownOncology @BrownPathology @BrownUPathoGP

Stock drama, cancer vaccine success, and new science — highlights from AACR #AACR23

https://apple.news/Ar3JRGhY1QuicH3Forp-KTg

Scholar, researcher, and musician, William MacDonald is a @BrownUniversity senior student who presented his novel results @BrownUCancer at the #AACR23 #AACR2023 meeting in Orlando. #eldeirylab @BrownMedicine

Researchers report on promising novel antitumor strategies in early-phase clinical trials
#AACR23

https://www.aacrmeetingnews.org/news/researchers-report-on-promising-novel-antitumor-strategies-in-early-phase-clinical-trials/

NCI Director @NCIDirector discusses Cancer Moonshot initiative and new National Cancer Plan
#AACR23

https://www.aacrmeetingnews.org/news/nci-director-discusses-cancer-moonshot-initiative-and-new-national-cancer-plan/

Sunrise in Orlando on last day of #AACR23

The @AACRPres Dr. Phil Greenberg makes remarks about some directions in the coming year including improving access to technology, communication with different constituencies and data science @AACR #AACR23

Great to spend time with colleagues at the @AACRPres reception @AACR #AACR23 @NeliMUlrich @JaniceM10 @DrJoannSweasy @LeonidasPlatan1 and Bob Vonderheide @PennCancer

Great chance to meet Dr. Nada Jabado, a pediatric oncologist at @mcgillu at the @AACR #AACR23 new @AACRPres reception.

Her group described histone H3.3 K27M and other mutations in glioblastomas in a 2012 Nature paper.

The TIC10/ONC201 drug discovered in #eldeirylab has clinical activity against these types of aggressive brain tumors.

RT @TumorBoardTues
#TumorBoardTuesday

There have been some exciting updates this weekend at #AACR23 on DDR and Breast Cancer‼️

So the discussion🗣️by @JenniferLitton & @marijasullivan tomorrow, 04/18/2023 at 8PM on treating early stage BRCA-mutated Breast Cancer is very timely⏲️

Vaccines could potentially eliminate cancers caused by human papillomavirus (HPV), but many people are unaware the virus causes cervical, anal, oral, and other cancers, researchers report at the AACR annual meeting (#AACR23).

https://www.cancerhealth.com/article/many-people-know-hpv-causes-cancer

RT @NCI_Bogler
How do you find good papers to read? How about letting NanCI by NCI help? In the new app for iOS & US NCI Cancer Centers you collect papers of interest & the AI will find others for - follow authors, build your network. Visit NCI booth at #AACR23 for more. https://bit.ly/3GKcIyb

Come one, come all, to our #AACR23 session "Immune Profiling and Immune Health in Cancer" at 12:30 pm. Featuring award-winning @EJohnWherry , incomparable Pam Ohashi (get well soon, Marta Luksza!), and me; all different approaches to cancer immunity. I know I'll learn something!
https://www.abstractsonline.com/pp8/#!/10828/session/62

Promising news from #AACR23: Moderna's personalized mRNA cancer vaccine plus Keytuda lowered risk of recurrence or death after surgery by 44% in people with advanced melanoma.

Cancer vaccines are a fascinating area of research -- the mRNA technology used for COVID vaccines was actually first developed for cancer -- and they're likely to be much better tolerated than current cancer treatments.

https://www.cancerhealth.com/article/mrna-vaccine-plus-keytruda-delays-melanoma-recurrence

Promising news from #AACR23: Moderna's personalized mRNA cancer vaccine plus Keytuda lowered risk of recurrence or death after surgery by 44% in people with advanced melanoma.

https://www.cancerhealth.com/article/mrna-vaccine-plus-keytruda-delays-melanoma-recurrence

Great to meet Amal El-Mabhouh, PhD at Novocure event this evening @AACR #AACR23 where we discussed our efforts with the AACR-Novocure grant.

Great to see Dr. Alex Adjei @AACR #AACR23

Some interesting posters that caught my attention at this morning’s poster session
@AACR
#AACR23

These include Dr. Ken Olive’s work at @Columbia on a promising pan-Ras inhibitor already in clinical trials in pancreatic and lung cancers, award winning work from San Antonio on ER-beta agonists to treat GBM, work at DFCI targeting MAPK in bladder cancer, and award-winning work from MDACC on loss of plasticity and immune evasion in SCLC

https://twitter.com/weldeiry/status/1648006513082900482?s=20

More of posters from
@BrownUCancer

@BrownMedicine
#eldeirylab
@shengliang15

@AACR
#AACR23
https://twitter.com/weldeiry/status/1648003778673516551?s=20

Running into colleagues
@AACR
#AACR23 Dr. Stan Lipkowitz at
@theNCI
, Dr. Margie Clapper at
@FoxChaseCancer
, Dr. Shiyong Sun
@EmoryUniversity

@WinshipAtEmory
and lab member
@AshDoesResearch

@BrownUPathoGP

Great conversation with Stan about connections between mitochondrial epigenetic control of chromatin and other exciting progress and collaboration at
@theNCI

Caught up with Margie about exciting cancer prevention drug screening efforts
@FoxChaseCancer
https://twitter.com/weldeiry/status/1647993126349426688?s=20